Literature DB >> 14732660

Digital epiluminescence microscopy monitoring of high-risk patients.

June K Robinson1, Brian J Nickoloff.   

Abstract

OBJECTIVE: To examine the outcome of digital epiluminescence microscopic (DELM) surveillance of atypical nevi in a high-risk population for 4 years.
DESIGN: Atypical, flat melanocytic lesions in 100 patients at high risk of developing melanoma were followed annually with DELM. Pigmentary changes or an increase in DELM diameter of 1 mm or greater was an indication to perform an excisional biopsy.
SETTING: Cardinal Bernardin Cancer Center Melanoma Program, Loyola University Health System, Maywood. PATIENTS: A consecutive sample of 3482 lesions from 100 patients (aged 18-65 years) with at least 2 images of the same lesion. MAIN OUTCOME MEASURES: The DELM change was confirmed by histopathologic examination. Patient confidence in and comfort with dermatologic surveillance and skin self-examination performance were assessed.
RESULTS: During annual surveillance with DELM, 5.5% of the lesions changed. Among the 193 excisional biopsy specimens there were 4 melanomas in situ, 169 dysplastic nevi, and 20 common nevi. Confidence in and comfort with surveillance and skin self-examination improved after DELM.
CONCLUSIONS: The criteria applied to detect substantial DELM changes were an increase in DELM diameter of 1 mm or greater and pigmentary changes, including radial streaming, focal enlargement, peripheral black dots, and "clumping" within the irregular pigment network. Use of DELM enhanced confidence in and comfort with care, which extended to performing more extensive skin self-examination.

Entities:  

Mesh:

Year:  2004        PMID: 14732660     DOI: 10.1001/archderm.140.1.49

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma.

Authors:  Gabriel Salerni; Cristina Carrera; Louise Lovatto; Joan Anton Puig-Butille; Celia Badenas; Estel Plana; Susana Puig; Josep Malvehy
Journal:  J Am Acad Dermatol       Date:  2011-06-16       Impact factor: 11.527

Review 3.  Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.

Authors:  Jennifer M Huang; Ijeuru Chikeka; Thomas J Hornyak
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

4.  Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting.

Authors:  Amy J Petty; Bradley Ackerson; Reed Garza; Michael Peterson; Beiyu Liu; Cynthia Green; Michelle Pavlis
Journal:  J Am Acad Dermatol       Date:  2020-01-11       Impact factor: 11.527

5.  Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma.

Authors:  Agnessa Gadeliya Goodson; Scott R Florell; Mark Hyde; Glen M Bowen; Douglas Grossman
Journal:  Dermatol Surg       Date:  2010-07       Impact factor: 3.398

Review 6.  [Strategies for the noninvasive diagnosis of melanoma].

Authors:  C Fink; H A Haenssle
Journal:  Hautarzt       Date:  2016-07       Impact factor: 0.751

7.  Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma.

Authors:  Stanley R Fuller; Glen M Bowen; Ben Tanner; Scott R Florell; Douglas Grossman
Journal:  Dermatol Surg       Date:  2007-10       Impact factor: 3.398

8.  Comparative Analysis of Diagnostic Techniques for Melanoma Detection: A Systematic Review of Diagnostic Test Accuracy Studies and Meta-Analysis.

Authors:  Alessia Blundo; Arianna Cignoni; Tommaso Banfi; Gastone Ciuti
Journal:  Front Med (Lausanne)       Date:  2021-04-21

9.  Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety.

Authors:  J Malvehy; A Hauschild; C Curiel-Lewandrowski; P Mohr; R Hofmann-Wellenhof; R Motley; C Berking; D Grossman; J Paoli; C Loquai; J Olah; U Reinhold; H Wenger; T Dirschka; S Davis; C Henderson; H Rabinovitz; J Welzel; D Schadendorf; U Birgersson
Journal:  Br J Dermatol       Date:  2014-10-19       Impact factor: 9.302

10.  Growth-Curve Modeling of Nevi With a Peripheral Globular Pattern.

Authors:  Shirin Bajaj; Stephen W Dusza; Michael A Marchetti; Xinyuan Wu; Maira Fonseca; Kivanc Kose; Johanna Brito; Cristina Carrera; Vanessa P Martins de Silva; Josep Malvehy; Susana Puig; Sarah Yagerman; Tracey N Liebman; Alon Scope; Allan C Halpern; Ashfaq A Marghoob
Journal:  JAMA Dermatol       Date:  2015-12-01       Impact factor: 10.282

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.